- Home
- MAIA vs LFVN Comparison
MAIA vs LFVN Comparison
Compare MAIA & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- LFVN
- Stock Information
- Founded
- MAIA 2018
- LFVN N/A
- Country
- MAIA United States
- LFVN United States
- Employees
- MAIA N/A
- LFVN N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- MAIA Health Care
- LFVN Health Care
- Exchange
- MAIA Nasdaq
- LFVN Nasdaq
- Market Cap
- MAIA 62.4M
- LFVN 127.0M
- IPO Year
- MAIA 2022
- LFVN N/A
- Fundamental
- Price
- MAIA $2.82
- LFVN $12.18
- Analyst Decision
- MAIA
- LFVN
- Analyst Count
- MAIA 0
- LFVN 0
- Target Price
- MAIA N/A
- LFVN N/A
- AVG Volume (30 Days)
- MAIA 60.0K
- LFVN 94.6K
- Earning Date
- MAIA 11-05-2024
- LFVN 10-29-2024
- Dividend Yield
- MAIA N/A
- LFVN 1.23%
- EPS Growth
- MAIA N/A
- LFVN 15.00
- EPS
- MAIA N/A
- LFVN 0.23
- Revenue
- MAIA N/A
- LFVN $200,164,000.00
- Revenue This Year
- MAIA N/A
- LFVN $4.36
- Revenue Next Year
- MAIA N/A
- LFVN $3.85
- P/E Ratio
- MAIA N/A
- LFVN $56.43
- Revenue Growth
- MAIA N/A
- LFVN N/A
- 52 Week Low
- MAIA $0.82
- LFVN $4.20
- 52 Week High
- MAIA $5.99
- LFVN $14.71
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- LFVN 51.31
- Support Level
- MAIA $2.36
- LFVN $11.68
- Resistance Level
- MAIA $2.72
- LFVN $14.71
- Average True Range (ATR)
- MAIA 0.22
- LFVN 0.79
- MACD
- MAIA 0.02
- LFVN -0.05
- Stochastic Oscillator
- MAIA 72.28
- LFVN 19.04
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.